Answers are grounded in this paper and cite their sources.
The biotransformation of mercury was monitored in Hymenoscyphus ericae (Read) Korf & Kernan, Neocosmospora vasinfecta E. F. Sm., and Verticillium terrestre (Link) Lindau following the exposure of these fungi to environmentally relevant doses of HgII(HgCl2) in aerated pH-controlled cultures. Mercury applied at 120 and 300 μg·L–1quickly associated with cells of N. vasinfecta. Within 3 h, approximately 80% of the remaining Hg in both treatments had been converted to β-HgS, and at 8 h, 15% and 53% of the original doses had been converted into volatile Hg0. Hymenoscyphus ericae was less efficient at converting HgIIto β-HgS, but it volatilized larger amounts of Hg0. A mercury-tolerant isolate of V. terrestre withstood levels of Hg in the parts per million. When exposed to 270, 1000, or 2000 μg·L–1HgCl2, 93% ± 3% of the amounts remaining in cultures of V. terrestre after 2 h was β-HgS. At 2 mg·L–1, 72% of the Hg was reduced to Hg0in 2 h. Volatilization accounts for the tolerance of V. terrestre to high doses of Hg, whereas the conversion of Hg to β-HgS was the major detoxifying mechanism at lower doses. The formation of β-HgS occurs preferentially with volatilization operating as the default pathway, when the former biotransformation mechanism is saturated.
No takes yet. Share an insight, caveat, or question.
Kelly et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: